Back to Screener

Baird Medical Investment Holdings Ltd Warrant (BDMDW)

Price$0.10

Favorite Metrics

Price vs S&P 500 (26W)88.90%
Price vs S&P 500 (4W)-18.75%

All Metrics

Price vs S&P 500 (YTD)61.78%
10-Day Avg Trading Volume0.00M
3-Month Avg Trading Volume0.01M
52-Week High$0.19
26-Week Price Return92.69%
13-Week Price Return69.86%
3-Month Return Std Dev222.17%
Year-to-Date Return62.50%
5-Day Price Return-15.22%
Month-to-Date Return-15.22%
Price vs S&P 500 (13W)69.80%
Beta-3.34x
52-Week Low$0.04

Industry Peers — Surgical & Medical Instruments(109)

SymbolP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
BDMDWBaird Medical Investment Holdings Ltd Warrant
$0.10
SYKStryker Corporation
5.17x11.84%64.57%19.43%$338.34
BSXBoston Scientific Corp.
4.58x15.16%69.01%18.00%$60.99
MMM3M Company
3.21x-4.97%39.92%18.55%$151.40
MDLNMedline Inc. Class A common stock
2.20x26.44%7.78%$48.26
BDXBecton, Dickinson and Co.
2.06x6.32%46.42%12.15%$158.64
RMDResMed Inc.
6.07x11.72%60.85%33.70%$226.14
DXCMDexCom, Inc.
5.33x19.33%62.09%19.56%$64.62
WSTWest Pharmaceutical Services, Inc.
6.29x7.44%35.91%19.03%$278.00
PODDInsulet Corporation
5.19x24.53%71.63%12.92%$200.87
PENPenumbra, Inc.
9.24x20.16%67.14%13.48%$329.71

About

Baird Medical Investment Holdings Ltd develops microwave ablation devices for minimally invasive tumor treatment in China. Its proprietary technology treats benign and malignant tumors including thyroid, liver, lung, and breast cancers, offering faster recovery and lower complication rates compared to traditional methods. The company operates in the growing minimally invasive oncology market in the PRC.